These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 5549166

  • 1. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].
    Mugler A.
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N, Griebsch A, Fink JK.
    Dtsch Med Wochenschr; 1970 Nov 27; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S, Laporte J.
    Arch Farmacol Toxicol; 1975 Mar 27; 1(1):43-6. PubMed ID: 1231648
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
    Mikkelsen WM, Robinson WD.
    Med Clin North Am; 1969 Nov 27; 53(6):1331-47. PubMed ID: 4900718
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Benziodarone in the basic treatment of gout].
    Ryckewaert A, Puel M, Kuntz D.
    Rev Rhum Mal Osteoartic; 1972 Jan 27; 39(1):33-9. PubMed ID: 5079688
    [No Abstract] [Full Text] [Related]

  • 10. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP.
    Munch Med Wochenschr; 1969 Feb 28; 111(9):491-5. PubMed ID: 5818966
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of gout and hyperuricemia.
    Wisner DE, Simkin PA.
    Prim Care; 1984 Jun 28; 11(2):283-94. PubMed ID: 6206519
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F, Saporta L, de Géry A, Jabre E.
    Rev Rhum Mal Osteoartic; 1970 Jun 28; 37(6):443-50. PubMed ID: 5453852
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperuricemia and gout.
    Klinenberg JR.
    Med Clin North Am; 1977 Mar 28; 61(2):299-312. PubMed ID: 323595
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.